Matthew A. Spear

Insider Reports History

Entity
Individual
Location
C/O Poseida Therapeutics, Inc., 4242 Campus Point Court, Suite 700, San Diego, CA
Signature
/s/ Harry J. Leonhardt, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Matthew A. Spear:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Poseida Therapeutics, Inc. Chief Medical Officer Common Stock 111K $596K $5.35 Mar 1, 2022 Direct
Poseida Therapeutics, Inc. Chief Medical Officer Employee Stock Option (Right to Buy) 72.6K Mar 1, 2022 Direct

Insider Reports Filed by Matthew A. Spear

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PSTX Poseida Therapeutics, Inc. Mar 1, 2022 2 $0 4 Mar 1, 2022 Chief Medical Officer
PSTX Poseida Therapeutics, Inc. Dec 6, 2021 2 $13.2K 4 Dec 8, 2021 Chief Medical Officer
PSTX Poseida Therapeutics, Inc. Sep 9, 2021 2 $13.2K 4 Sep 10, 2021 Chief Medical Officer
PSTX Poseida Therapeutics, Inc. Aug 20, 2021 3 -$29.9K 4 Aug 24, 2021 Chief Medical Officer
PSTX Poseida Therapeutics, Inc. Jul 28, 2021 2 $26.4K 4 Jul 30, 2021 Chief Medical Officer
PSTX Poseida Therapeutics, Inc. Jun 17, 2021 2 $6.61K 4 Jun 21, 2021 Chief Medical Officer
PSTX Poseida Therapeutics, Inc. Jun 11, 2021 3 -$32.5K 4 Jun 14, 2021 Chief Medical Officer